Previous studies on myositis have suggested that these disorders are autoim
mune in nature, and have provided evidence that myositis-specific autoantib
odies and autoreactive T cells are present in affected patients. Recent stu
dies provide evidence for the upregulation of various immunologically relev
ant cell surface molecules, cytokines, and chemokines, suggesting active ce
ll-cell interactions. Understanding these interactions may provide novel th
erapeutic targets in these diseases. The role of skeletal muscle cells and
their contribution to the immune response has become more important as a re
sult of the advent of therapeutic strategies such as myoblast implantation,
DNA vaccination, and gene therapy for various disease conditions. Understa
nding the immunologic capabilities of skeletal muscle cells may provide imp
ortant clues not only to the mechanisms of the autoimmune response, but als
o to the use of skeletal muscle as the site of transgene expression to corr
ect genetic defects. Curr Opin Rheumatol 2001, 13:461-468 (C) 2001 Lippinco
tt Williams & Wilkins, Inc.